Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$MCET its looking great! Great Bid Support! The way up is free.
$MCET its looking great! Great Bid Support! The way up is free.
$MCET Fa2N-4 cell lines MULTI BAGGER! GOING UP https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
$MCET Fa2N-4 cell lines MULTI BAGGER! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Market Makers bids confirmed with more buys per day! Uptrend decisions! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Market Makers bids confirmed with more buys per day! Uptrend decisions! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
$IDGC buy alert)))))))
$IDGC ***RE-INSTATEMENT** AND NEW WEBSITE : Get a certificate of good standing is https://t.co/4nxZ5bTPNp @GainsDayTrades @greatstockpicks @AlexDelarge6553 @TESLAQUEENOTC @Chivitotrader @KpPeeps @kapoclain @MONEYEMPIRE @pennystockmomo @Zipcash1
— THE FINAL COUNTDOWN (@READY_2_PROFIT) January 15, 2021
$IDGC buy alert)))))))
$IDGC ***RE-INSTATEMENT** AND NEW WEBSITE : Get a certificate of good standing is https://t.co/4nxZ5bTPNp @GainsDayTrades @greatstockpicks @AlexDelarge6553 @TESLAQUEENOTC @Chivitotrader @KpPeeps @kapoclain @MONEYEMPIRE @pennystockmomo @Zipcash1
— THE FINAL COUNTDOWN (@READY_2_PROFIT) January 15, 2021
$MCET HUGE LOADING! $TRONG HOLD! GREAT SUPPORT!
$MCET HUGE LOADING! $TRONG HOLD! GREAT SUPPORT!
$IDGC REGISTRATION and UPDATING PROCEDURES FOR COMMERCIAL AND GOVERNMENT ENTITY (CAGE) CODE or NATO CAGE (NCAGE)
https://eportal.nspa.nato.int/AC135Public/Docs/US%20Instructions%20for%20NSPA%20NCAGE.pdf
Farallon Inc. Status: Active
DUNS: 081494822
CAGE Code: 89WM4
Has Active Exclusion?: No DoDAAC:
Expiration Date: 01/04/2022 Debt Subject to Offset?: No
Purpose of Registration: All Awards
https://www.sam.gov/SAM/pages/public/entitySearch/entitySearchEntityOverview.jsf
$IDGC REGISTRATION and UPDATING PROCEDURES FOR COMMERCIAL AND GOVERNMENT ENTITY (CAGE) CODE or NATO CAGE (NCAGE)
https://eportal.nspa.nato.int/AC135Public/Docs/US%20Instructions%20for%20NSPA%20NCAGE.pdf
Farallon Inc. Status: Active
DUNS: 081494822
CAGE Code: 89WM4
Has Active Exclusion?: No DoDAAC:
Expiration Date: 01/04/2022 Debt Subject to Offset?: No
Purpose of Registration: All Awards
https://www.sam.gov/SAM/pages/public/entitySearch/entitySearchEntityOverview.jsf
$IDGC More Big Buys Action NOW! Thats Amazing!!!
$IDGC More Big Buys Action NOW! Thats Amazing!!!
$IDGC Subsidiaries Noveda Technologies, Inc. KEY FACTS $$$$$$$$$$
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160995172
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160995318
$IDGC Subsidiaries Noveda Technologies, Inc. KEY FACTS $$$$$$$$$$
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160995172
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160995318
$IDGC Absolutely Confirmed! For all! Please read the info!
Last quarter filings! 11/17/2019 Quarterly Report - Quarterly Report Q3 2019 Supplemental
>>>>> 5) Issuer’s Business, Products and Services <<<<<
https://backend.otcmarkets.com/otcapi/company/financial-report/234964/content
CERTIFICATE OF DOCUMENT FILED / Statement Curing Delinquency Page 1-4. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160969871
Get a certificate of good standing
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160969369
The content is confirmed! IoT 4.0 and Noveda Technologies!
https://www.otcmarkets.com/stock/IDGC/news/ID-Global-Corp-Announces-Corporate-Update-Management-Structure-after-Acquisition-by-Liberty-Capital-Group-of-San-Diego?id=228525
https://www.otcmarkets.com/stock/IDGC/news/IDGC-Completes-Strategic-Investment-In-Noveda-Technologies?id=233617
Liberty Capital Group. has the leadership position! Idglobal corporation subsidiaries is Farallon, inc., Prestige Liquids, LLC and Noveda Technologies, Inc.
Makes Idglobal also profit on Farallon, Inc.? Please review! They have a great many contracts.
https://govtribe.com/vendors/farallon-inc-dot-89wm4
PDF FORMAT!
Select Download FAR Report to review the Representations and Certifications for FARALLON INC. <<<<<<<
Select Download FAR & DFARS Report to review the Representations and Certifications for FARALLON INC. <<<<<<<
https://beta.sam.gov/entity/081494822?keywords=%22Farallon%20Inc.%22&sort=-relevance&index=&is_active=true&page=1&status=active
$IDGC Absolutely Confirmed! For all! Please read the info!
Last quarter filings! 11/17/2019 Quarterly Report - Quarterly Report Q3 2019 Supplemental
>>>>> 5) Issuer’s Business, Products and Services <<<<<
https://backend.otcmarkets.com/otcapi/company/financial-report/234964/content
CERTIFICATE OF DOCUMENT FILED / Statement Curing Delinquency Page 1-4. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160969871
Get a certificate of good standing
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160969369
The content is confirmed! IoT 4.0 and Noveda Technologies!
https://www.otcmarkets.com/stock/IDGC/news/ID-Global-Corp-Announces-Corporate-Update-Management-Structure-after-Acquisition-by-Liberty-Capital-Group-of-San-Diego?id=228525
https://www.otcmarkets.com/stock/IDGC/news/IDGC-Completes-Strategic-Investment-In-Noveda-Technologies?id=233617
Liberty Capital Group. has the leadership position! Idglobal corporation subsidiaries is Farallon, inc., Prestige Liquids, LLC and Noveda Technologies, Inc.
Makes Idglobal also profit on Farallon, Inc.? Please review! They have a great many contracts.
https://govtribe.com/vendors/farallon-inc-dot-89wm4
PDF FORMAT!
Select Download FAR Report to review the Representations and Certifications for FARALLON INC. <<<<<<<
Select Download FAR & DFARS Report to review the Representations and Certifications for FARALLON INC. <<<<<<<
https://beta.sam.gov/entity/081494822?keywords=%22Farallon%20Inc.%22&sort=-relevance&index=&is_active=true&page=1&status=active
Toll Like Receptor 3 Sales Market Size with Top Countries Industry Chain Structure, Competitive Landscape, New Projects and Investment Analysis By 360 Research Report
Published: Jan. 6, 2021 at 12:13 a.m. ET
0
Global Toll Like Receptor 3 Sales Market report provides market status of the Toll Like Receptor 3 Sales manufacturers with best facts and figures, meaning, definition, SWOT analysis, expert opinions, latest developments and the report tracks primary trends that decide future growth prospects in the global market.
Email icon
Facebook icon
Twitter icon
Linkedin icon
Flipboard icon
Print icon
Resize icon
The MarketWatch News Department was not involved in the creation of this content.
Jan 06, 2021 (The Expresswire) -- “Toll Like Receptor 3 Sales Market" report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, threats, and global markets including progress trends, competitive landscape analysis, and key regions expansion status.This report is comprehensive numerical analyses of the Toll Like Receptor 3 Sales industry and provides data for making strategies to increase the market growth and success. Toll Like Receptor 3 Sales Market finds essential elements of thethis market in light of present industry, this market requests, business methodologies used by Toll Like Receptor 3 Sales Market players and the future prospects from different edges in detail.
Global Toll Like Receptor 3 SalesMarket Report2021-2026contains systematic and point to point information regarding to Toll Like Receptor 3 SalesIndustry and growing due to growing requirements for quality inspection and surge in demand. It also provides pin-point analysis for changing competitive dynamics and provides healthy CAGR during the period2026and calculate the market size,Toll Like Receptor 3 Sales Sales, Price, Revenue, Gross Margin and Market Share, cost structure and growth rate.
Request for a Sample PDF of Report at -https://www.360researchreports.com/enquiry/request-sample/16802718
The research covers the current Toll Like Receptor 3 Salesmarket size of the market and its growth rates based on 6-year records with company outline of TOPKEY PLAYERS/MANUFACTURERS:
? Biomics Biotechnologies Co., Ltd.
? Hemispherx Biopharma, Inc.
? Idera Pharmaceuticals, Inc.
? Innate Pharma S.A.
? Johnson and Johnson
? MultiCell Technologies, Inc.
? Oncovir, Inc.
? Tollys S.A.S
Final Report will add the analysis of the impact of COVID-19 on this industry.
TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT - REQUEST SAMPLE
Brief Description of Toll Like Receptor 3 Sales Market:
Market Analysis and Insights: Global Toll Like Receptor 3 Market
The global Toll Like Receptor 3 market size is projected to reach USD million by 2026, from USD million in 2020, at a CAGR of % during 2021-2026.
Global Toll Like Receptor 3 Scope and Market Size
The global Toll Like Receptor 3 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Toll Like Receptor 3 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
By the product type, the Toll Like Receptor 3 Sales marketis primarily split into:
? P-7
? Poly-ICLC
? PrEP-001
? Others
By the end users/application, Toll Like Receptor 3 Sales marketreport coversthe following segments:
? Hepatitis B
? Liver Cancer
? Prostate Cancer
? Others
The key regions covered in theToll Like Receptor 3 Sales market report are:
? North America (United States, Canada and Mexico)
? Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
? Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
? South America (Brazil, Argentina, Columbia etc.)
? Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Key Reasons to Purchase:
? To gain insightful analyses of the market and have comprehensive understanding of the global Toll Like Receptor 3 Sales market trend and its commercial landscape.
? Assess the production processes, major issues, and solutions to mitigate the development risk.
? To understand the most affecting driving and restraining forces in the market and its impact in the global Toll Like Receptor 3 Sales market growth.
? Learn about the market strategies that are being adopted by leading respective organizations.
? To understand the future outlook and prospects for the Toll Like Receptor 3 Sales market forecast.
? Besides the standard structure reports, we also provide custom research according to specific requirements.
Inquire or share your questions if any before the purchasing this report -https://www.360researchreports.com/enquiry/pre-order-enquiry/16802718
Table of Contents with Major Points:
Detailed TOC of Global Toll Like Receptor 3 SalesMarket Research Report2021-2026, by Manufacturers, Regions, Types and Applications
1 Toll Like Receptor 3 Sales MarketOverview
1.1ProductOverviewandScopeof Toll Like Receptor 3 Sales
1.2 Toll Like Receptor 3 Sales SegmentbyType
1.3 Toll Like Receptor 3 Sales SegmentbyApplication
1.4Global Toll Like Receptor 3 Sales MarketSizeEstimatesandForecasts
1.5 Toll Like Receptor 3 Sales Industry
1.6 Toll Like Receptor 3 Sales MarketTrends
2Global Toll Like Receptor 3 Sales MarketCompetitionbyManufacturers
2.1Global Toll Like Receptor 3 Sales SalesMarketSharebyManufacturers(2015-2021)
2.2Global Toll Like Receptor 3 Sales RevenueSharebyManufacturers(2015-2021)
2.3Global Toll Like Receptor 3 Sales AveragePricebyManufacturers(2015-2021)
2.4Manufacturers Toll Like Receptor 3 Sales ManufacturingSites,AreaServed,ProductType
2.5 Toll Like Receptor 3 Sales MarketCompetitiveSituationandTrends
2.6ManufacturersMergersandAcquisitions,ExpansionPlans
2.7PrimaryInterviewswithKey Toll Like Receptor 3 Sales Players(OpinionLeaders)
Get a Sample PDF ofToll Like Receptor 3 SalesMarket Report2021
3 Toll Like Receptor 3 Sales RetrospectiveMarketScenariobyRegion
3.1Global Toll Like Receptor 3 Sales RetrospectiveMarketScenarioinSalesbyRegion:2015-2021
3.2Global Toll Like Receptor 3 Sales RetrospectiveMarketScenarioinRevenuebyRegion:2015-2021
3.3NorthAmerica Toll Like Receptor 3 Sales MarketFactsandFiguresbyCountry
3.4Europe Toll Like Receptor 3 Sales MarketFactsandFiguresbyCountry
3.5AsiaPacific Toll Like Receptor 3 Sales MarketFactsandFiguresbyRegion
3.6LatinAmerica Toll Like Receptor 3 Sales MarketFactsandFiguresbyCountry
3.7MiddleEastandAfrica Toll Like Receptor 3 Sales MarketFactsandFiguresbyCountry
4Global Toll Like Receptor 3 Sales HistoricMarketAnalysisbyType
4.1Global Toll Like Receptor 3 Sales SalesMarketSharebyType(2015-2021)
4.2Global Toll Like Receptor 3 Sales RevenueMarketSharebyType(2015-2021)
4.3Global Toll Like Receptor 3 Sales PriceMarketSharebyType(2015-2021)
4.4Global Toll Like Receptor 3 Sales MarketSharebyPriceTier(2015-2021):Low-End,Mid-RangeandHigh-End
5Global Toll Like Receptor 3 Sales HistoricMarketAnalysisbyApplication
5.1Global Toll Like Receptor 3 Sales SalesMarketSharebyApplication(2015-2021)
5.2Global Toll Like Receptor 3 Sales RevenueMarketSharebyApplication(2015-2021)
5.3Global Toll Like Receptor 3 Sales PricebyApplication(2015-2021)
6CompanyProfilesandKeyFiguresin Toll Like Receptor 3 Sales Business
7 Toll Like Receptor 3 Sales ManufacturingCostAnalysis
8MarketingChannel,DistributorsandCustomers
9MarketDynamics
9.1MarketTrends
9.2OpportunitiesandDrivers
9.3Challenges
9.4Porter'sFiveForcesAnalysis
10GlobalMarketForecast
10.1Global Toll Like Receptor 3 Sales MarketEstimatesandProjectionsbyType
10.2 Toll Like Receptor 3 Sales MarketEstimatesandProjectionsbyApplication
10.3 Toll Like Receptor 3 Sales MarketEstimatesandProjectionsbyRegion
10.4NorthAmerica Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
10.5Europe Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
10.6AsiaPacific Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
10.7LatinAmerica Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
10.8MiddleEastandAfrica Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
11ResearchFindingandConclusion
12MethodologyandDataSource
https://www.marketwatch.com/press-release/toll-like-receptor-3-sales-market-size-with-top-countries-industry-chain-structure-competitive-landscape-new-projects-and-investment-analysis-by-360-research-report-2021-01-06
Toll Like Receptor 3 Sales Market Size with Top Countries Industry Chain Structure, Competitive Landscape, New Projects and Investment Analysis By 360 Research Report
Published: Jan. 6, 2021 at 12:13 a.m. ET
0
Global Toll Like Receptor 3 Sales Market report provides market status of the Toll Like Receptor 3 Sales manufacturers with best facts and figures, meaning, definition, SWOT analysis, expert opinions, latest developments and the report tracks primary trends that decide future growth prospects in the global market.
Email icon
Facebook icon
Twitter icon
Linkedin icon
Flipboard icon
Print icon
Resize icon
The MarketWatch News Department was not involved in the creation of this content.
Jan 06, 2021 (The Expresswire) -- “Toll Like Receptor 3 Sales Market" report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, threats, and global markets including progress trends, competitive landscape analysis, and key regions expansion status.This report is comprehensive numerical analyses of the Toll Like Receptor 3 Sales industry and provides data for making strategies to increase the market growth and success. Toll Like Receptor 3 Sales Market finds essential elements of thethis market in light of present industry, this market requests, business methodologies used by Toll Like Receptor 3 Sales Market players and the future prospects from different edges in detail.
Global Toll Like Receptor 3 SalesMarket Report2021-2026contains systematic and point to point information regarding to Toll Like Receptor 3 SalesIndustry and growing due to growing requirements for quality inspection and surge in demand. It also provides pin-point analysis for changing competitive dynamics and provides healthy CAGR during the period2026and calculate the market size,Toll Like Receptor 3 Sales Sales, Price, Revenue, Gross Margin and Market Share, cost structure and growth rate.
Request for a Sample PDF of Report at -https://www.360researchreports.com/enquiry/request-sample/16802718
The research covers the current Toll Like Receptor 3 Salesmarket size of the market and its growth rates based on 6-year records with company outline of TOPKEY PLAYERS/MANUFACTURERS:
? Biomics Biotechnologies Co., Ltd.
? Hemispherx Biopharma, Inc.
? Idera Pharmaceuticals, Inc.
? Innate Pharma S.A.
? Johnson and Johnson
? MultiCell Technologies, Inc.
? Oncovir, Inc.
? Tollys S.A.S
Final Report will add the analysis of the impact of COVID-19 on this industry.
TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT - REQUEST SAMPLE
Brief Description of Toll Like Receptor 3 Sales Market:
Market Analysis and Insights: Global Toll Like Receptor 3 Market
The global Toll Like Receptor 3 market size is projected to reach USD million by 2026, from USD million in 2020, at a CAGR of % during 2021-2026.
Global Toll Like Receptor 3 Scope and Market Size
The global Toll Like Receptor 3 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Toll Like Receptor 3 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
By the product type, the Toll Like Receptor 3 Sales marketis primarily split into:
? P-7
? Poly-ICLC
? PrEP-001
? Others
By the end users/application, Toll Like Receptor 3 Sales marketreport coversthe following segments:
? Hepatitis B
? Liver Cancer
? Prostate Cancer
? Others
The key regions covered in theToll Like Receptor 3 Sales market report are:
? North America (United States, Canada and Mexico)
? Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
? Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
? South America (Brazil, Argentina, Columbia etc.)
? Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Key Reasons to Purchase:
? To gain insightful analyses of the market and have comprehensive understanding of the global Toll Like Receptor 3 Sales market trend and its commercial landscape.
? Assess the production processes, major issues, and solutions to mitigate the development risk.
? To understand the most affecting driving and restraining forces in the market and its impact in the global Toll Like Receptor 3 Sales market growth.
? Learn about the market strategies that are being adopted by leading respective organizations.
? To understand the future outlook and prospects for the Toll Like Receptor 3 Sales market forecast.
? Besides the standard structure reports, we also provide custom research according to specific requirements.
Inquire or share your questions if any before the purchasing this report -https://www.360researchreports.com/enquiry/pre-order-enquiry/16802718
Table of Contents with Major Points:
Detailed TOC of Global Toll Like Receptor 3 SalesMarket Research Report2021-2026, by Manufacturers, Regions, Types and Applications
1 Toll Like Receptor 3 Sales MarketOverview
1.1ProductOverviewandScopeof Toll Like Receptor 3 Sales
1.2 Toll Like Receptor 3 Sales SegmentbyType
1.3 Toll Like Receptor 3 Sales SegmentbyApplication
1.4Global Toll Like Receptor 3 Sales MarketSizeEstimatesandForecasts
1.5 Toll Like Receptor 3 Sales Industry
1.6 Toll Like Receptor 3 Sales MarketTrends
2Global Toll Like Receptor 3 Sales MarketCompetitionbyManufacturers
2.1Global Toll Like Receptor 3 Sales SalesMarketSharebyManufacturers(2015-2021)
2.2Global Toll Like Receptor 3 Sales RevenueSharebyManufacturers(2015-2021)
2.3Global Toll Like Receptor 3 Sales AveragePricebyManufacturers(2015-2021)
2.4Manufacturers Toll Like Receptor 3 Sales ManufacturingSites,AreaServed,ProductType
2.5 Toll Like Receptor 3 Sales MarketCompetitiveSituationandTrends
2.6ManufacturersMergersandAcquisitions,ExpansionPlans
2.7PrimaryInterviewswithKey Toll Like Receptor 3 Sales Players(OpinionLeaders)
Get a Sample PDF ofToll Like Receptor 3 SalesMarket Report2021
3 Toll Like Receptor 3 Sales RetrospectiveMarketScenariobyRegion
3.1Global Toll Like Receptor 3 Sales RetrospectiveMarketScenarioinSalesbyRegion:2015-2021
3.2Global Toll Like Receptor 3 Sales RetrospectiveMarketScenarioinRevenuebyRegion:2015-2021
3.3NorthAmerica Toll Like Receptor 3 Sales MarketFactsandFiguresbyCountry
3.4Europe Toll Like Receptor 3 Sales MarketFactsandFiguresbyCountry
3.5AsiaPacific Toll Like Receptor 3 Sales MarketFactsandFiguresbyRegion
3.6LatinAmerica Toll Like Receptor 3 Sales MarketFactsandFiguresbyCountry
3.7MiddleEastandAfrica Toll Like Receptor 3 Sales MarketFactsandFiguresbyCountry
4Global Toll Like Receptor 3 Sales HistoricMarketAnalysisbyType
4.1Global Toll Like Receptor 3 Sales SalesMarketSharebyType(2015-2021)
4.2Global Toll Like Receptor 3 Sales RevenueMarketSharebyType(2015-2021)
4.3Global Toll Like Receptor 3 Sales PriceMarketSharebyType(2015-2021)
4.4Global Toll Like Receptor 3 Sales MarketSharebyPriceTier(2015-2021):Low-End,Mid-RangeandHigh-End
5Global Toll Like Receptor 3 Sales HistoricMarketAnalysisbyApplication
5.1Global Toll Like Receptor 3 Sales SalesMarketSharebyApplication(2015-2021)
5.2Global Toll Like Receptor 3 Sales RevenueMarketSharebyApplication(2015-2021)
5.3Global Toll Like Receptor 3 Sales PricebyApplication(2015-2021)
6CompanyProfilesandKeyFiguresin Toll Like Receptor 3 Sales Business
7 Toll Like Receptor 3 Sales ManufacturingCostAnalysis
8MarketingChannel,DistributorsandCustomers
9MarketDynamics
9.1MarketTrends
9.2OpportunitiesandDrivers
9.3Challenges
9.4Porter'sFiveForcesAnalysis
10GlobalMarketForecast
10.1Global Toll Like Receptor 3 Sales MarketEstimatesandProjectionsbyType
10.2 Toll Like Receptor 3 Sales MarketEstimatesandProjectionsbyApplication
10.3 Toll Like Receptor 3 Sales MarketEstimatesandProjectionsbyRegion
10.4NorthAmerica Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
10.5Europe Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
10.6AsiaPacific Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
10.7LatinAmerica Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
10.8MiddleEastandAfrica Toll Like Receptor 3 Sales EstimatesandProjections(2021-2026)
11ResearchFindingandConclusion
12MethodologyandDataSource
https://www.marketwatch.com/press-release/toll-like-receptor-3-sales-market-size-with-top-countries-industry-chain-structure-competitive-landscape-new-projects-and-investment-analysis-by-360-research-report-2021-01-06
$MCET Info: Multicell Technologies has two active programs! NATO Commercial and Government Entity NCAGE481X3 and COMMERCIAL AND GOVERNMENT ENTITY PROGRAM CAGE481X3
A - ACTIVE record NCAGE481X3 https://eportal.nspa.nato.int/AC135Public/CageTool/cage-view/481x3
Status Active CAGE481X3 https://cage.dla.mil/Search/Details?id=894402
$MCET Info: Multicell Technologies has two active programs! NATO Commercial and Government Entity NCAGE481X3 and COMMERCIAL AND GOVERNMENT ENTITY PROGRAM CAGE481X3
A - ACTIVE record NCAGE481X3 https://eportal.nspa.nato.int/AC135Public/CageTool/cage-view/481x3
Status Active CAGE481X3 https://cage.dla.mil/Search/Details?id=894402
$MCET U.S. Companies Developing RNA-targeted Therapies
Presentation PanHellenic Congress of Cardiology Oct 18, 2019
microRNA and Other Nucleic Acid = Multicell Technologies,...
https://static.livemedia.gr/services/hcs/userfiles/usid0_20191018064742_1tsimikas064741.pdf
$MCET U.S. Companies Developing RNA-targeted Therapies
Presentation PanHellenic Congress of Cardiology Oct 18, 2019
microRNA and Other Nucleic Acid = Multicell Technologies,...
https://static.livemedia.gr/services/hcs/userfiles/usid0_20191018064742_1tsimikas064741.pdf
$MCET Question: How many millions of dollars does the coding NAICS Code 541711, NCAGE CODE 481X3 and CAGE CODE 481X3 Multicell Technologies per year?
$MCET Question: How many millions of dollars does the coding NAICS Code 541711, NCAGE CODE 481X3 and CAGE CODE 481X3 Multicell Technologies per year?
Next Step hit up! Its coming! Market Makers confirm! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Next Step hit up! Its coming! Market Makers confirm! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Green Team Southwestern and the City of Winfield offers E-Waste Recycling Event February 2
Fri, 01/22/2021
Winfield, Kan. — The Green Team of Southwestern College will again collaborate with the City of Winfield for an e-waste recycling event from 3 to 6 p.m. Tuesday, Feb. 2, at the Arkansas City/Winfield Recycling Center located at 7th Avenue and D Street in Strother Field. Use the east driveway to enter the recycling center building and exit out the west driveway after dropping off electronics. The Green Team will be accepting donations to help offset the cost of transporting electronics to the recycler.
“Recycling electronic devices is very important for our planet and our community,” says Jason Speegle, director of the Green Team at Southwestern College. “When electronics go to the landfill, they have the potential to leach hazardous toxins into our soil and drinking water. Recycling electronics ensures that they are disposed of safely and many of the components can be reused. During the past seven years, this event has collected and recycled over 100,000 pounds of obsolete electronic devices from the Winfield and Ark City communities.”
Businesses and individuals may bring items to the event. GON Recycling will collect the items and process them for recycling. GON Recycling guarantees 100 percent security on all hard drives and customer information. They are e-Stewards, R2 and ISO 14001 certified.
GON Recycling accepts the following electronic items: computers, laptops, servers, network equipment, LCD Monitors, printers, scanners, fax machines, copiers, POS scanners and equipment, stereo equipment, small household appliances such as toasters, irons, and coffee pots, telephones, telecommunications equipment, phone systems, security equipment, industrial equipment, UPS systems, cell phones, VCRs, radios, keyboards and computer mice, lead acid batteries, re-chargeable batteries, industrial control panels, ink and toner.
Medical equipment that has been inspected and decontaminated of blood borne pathogens, fluids, solvents, pressure gases or radioactive sources is also accepted. Proof of decontamination is required. This can be a decontaminated sticker or paperwork attached to the unit.
The Green Team and GON Recycling will recycle CRT TVs and monitors for a $5 fee. Everything else is no cost. If you need to recycle these items, please bring the funds to pay the recycling fee.
GON Recycling cannot accept these items: refrigerators, air conditioners that are not properly drained, light bulbs, smoke alarms, alkaline batteries and items that contain blood borne pathogens, fluids, solvents, Freon, pres sure gases, radioactive or gasoline sources.
“On behalf of the Green Team at Southwestern, and the City of Winfield, we are excited to continue to be able to provide this service to the Winfield community,” Speegle says.
For questions about recycling, please contact Jason Speegle at (620) 229-6311 or by email at jason.speegle@sckans. edu.
Southwestern College is a private liberal arts college, founded in 1885 by Methodists in south central Kansas. Today its Winfield campus is the residential hub that guides students to lives of meaning and service, with well-rounded academic and extra-curricular offerings attracting traditional-aged students from throughout the nation and world. Southwestern College Professional Studies provides options for online students in any location and has been named a top provider for persons serving in the military. The college continues to be affiliated with the United Methodist Church and is accredited by the Higher Learning Commission to offer bachelor’s, master’s, and doctoral degrees.
https://www.poncacitynews.com/news/green-team-southwestern-and-city-winfield-offers-e-waste-recycling-event-february-2
Pandemic-Driven IT Investment Puts New Focus on Growing E-Waste Crisis
January 21, 2021
eWEEK DATA POINTS: At some point, once this public health crisis passes, many employees will return to their offices. The question then is what will happen to excess IT equipment: Will it add to an already significant global e-waste problem?
The global COVID-19 pandemic dramatically reshaped almost every facet of our lives, including how and where we work. Enterprises across the world adopted a work-from-home strategy that triggered a massive surge of IT investment to equip workers with the computers, laptops and smartphones they required to be productive.
At some point, once this public health crisis passes, many employees will return to their offices. The question then is what will happen to excess IT equipment: Will it add to an already growing global e-waste problem? More than 53 million metric tons of e-waste was produced in 2019 alone. Or will businesses find other ways to responsibly deal with the IT assets they no longer need?
Fortunately, Blancco Technology Group’s new research study, "The Rising Tide of E-Waste," conducted in partnership with Coleman Parkes Research, shows some positive change in how global enterprises are addressing the e-waste crisis.
In this eWEEK Data Points article, Fredrik Forslund, vice-president of enterprise and cloud erasure at Blancco, highlights the most important findings from the report. Survey responses from 600 C-level executives and IT decision makers at global enterprises with 5,000+ employees located in the U.S., Japan, Germany, France and the U.K have resulted in four key considerations for enterprises as we head into 2021.
Data Point No. 1: The pandemic has fueled massive IT asset investment in the U.S. and increased business risk.
In line with their European counterparts, 97% of U.S. executives said that COVID-19 necessitated the short-term investment in technology, with 77% buying new devices. When asked what will happen to new and used devices after they’re no longer needed, the responses were mixed: 27% of U.S. respondents said laptops would be erased and then resold.
Another 24% said the devices would be erased to be reused internally. An additional 7% reported these devices would be erased and recycled, and 12% of U.S.-based organizations will send them to an ITAD for processing. Two-thirds of respondents recognize that their organizations are at risk of a data breach or regulatory compliance failure from the purchase and potential mismanagement of both new and previously owned devices, especially with so many of those devices now located in home offices across the country.
Data Point No. 2: Nearly half of global organizations have created new roles for executing e-waste policies.
Nearly half (47%) of respondents from global enterprises stated they’ve created new roles to execute e-waste policies, especially those in finance (51%) and legal (54%), perhaps driven by the number of new and used assets purchased due to the pandemic and the need to manage their new technology inventory responsibly.
This new attitude toward asset management is reflected in the high number of U.S. survey takers (88%) who said, “We must take a serious view on ensuring all devices used to equip the workforce throughout the COVID-19 pandemic are appropriately stored and disposed of." This is an encouraging sign that establishing corporate social responsibility (CSR) and e-waste policies is becoming more widespread globally and a clear indication that organizations are taking the e-waste crisis more seriously.
Data Point No. 3: Communication is the weak link hindering the success of e-waste policies.
The uncertainty of how to inform employees of e-waste policies is a global issue. The report found that only half (50%) of global enterprises surveyed have a dedicated e-waste policy that was communicated across the whole organization, with 56% of U.S. respondents in agreement. Nearly half (47%) of global enterprises and 44% in the U.S. are “uncertain” about how best to communicate e-waste policies. This challenge is exacerbated by the fact that the task of being responsible for e-waste and CSR policy communications lacks ownership.
In the U.S., 36% of enterprises have an e-waste policy in place for end-of-life device management, although such policies are not yet being communicated or implemented. Nearly a third (32%) of U.S. respondents said the reason their e-waste policies hadn’t been communicated was that no one had taken control of them.
One of the key reasons for a lack of clear direction and ownership may be due to the fact that 45% of U.S. respondents claim their organizations view CSR policies as low priority lacking support from senior stakeholders. The findings bring to light a consciousness that e-waste is a serious issue, but there is still an obvious lack of ownership for policies that recognize the urgent nature of the e-waste issue and which reflect the new and changing nature of remote work environments.
Data Point No. 4: Nearly one-third of U.S. respondents still think destroying equipment is better for the environment.
When we conducted a similar survey in the third quarter of 2019, 30% of U.S. respondents said they were physically destroying end-of-life assets because it was better for the environment. Nearly one year later, this number has grown to 32%.
The misconception about destruction being better for the environment is clearly a myth that persists. The fact is that electronics dumped in a landfill contain toxic and hazardous materials, such as mercury and lead, which are extremely harmful to the environment and to anyone who might be exposed to them. When asked to dig further into the rationale behind the belief that device destruction is better for the environment, just under half (49%) said they believe it to be more energy-efficient while 46% believed some of the waste can be recycled or reused.
It's a positive step to see respondents acknowledge that they plan to recycle or reuse some of the waste; however, this does not detract from the fact that organizations continue to dump toxic electronic waste in landfills.
Data Point No. 5: Conclusions
The findings from this study are encouraging, showing improvement in attitudes and acknowledgment of the growing global e-waste crisis. As 2021 gets under way, companies should continue to make e-waste a high priority by both developing and executing specific CSR policies that incorporate e-waste.
However, without stakeholder commitment to communicating and carrying out these policies, they will remain ineffective. Appointing dedicated CSR “czars” who have the responsibility, authority and means to enforce the policies will help organizations do their part to combat the global e-waste crisis while maintaining the highest possible data security standards.
https://www.eweek.com/pc-hardware/pandemic-driven-it-investment-puts-new-focus-on-growing-e-waste-crisis
$GSFI Green Stream Holdings Anticipates Sunny Forecast for Renewable Energy - Market Rally as U.S. Stocks Soar Just Hours Before Biden Inauguration
JAN 20, 2021 11:59AM EST
Malibu, California--(Newsfile Corp. - January 20, 2021) - Green Stream Holdings Inc. (OTC PINK: GSFI) ("the Company") ("Green Stream") (http://www.GreenRainSolar.com ), an emerging leader in the solar utility and finance space, announces today what it believes to be a new era for Renewable Energy and its Solar Utilities/Financing model as stocks rise in advance of the inauguration of Joe Biden as the 46th President of the United States.
To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_002full.jpg
Biden's agenda is to transition the U.S. from an economy reliant on fossil fuels to one driven by wind, solar and other renewable-energy sources. The shift from fossil-fuel companies to renewable-energy firms accelerated during the Trump administration, despite the president's vows to support the U.S. coal and petroleum industries.
Big and small investors have moved their assets away from fossil-fuel producers and toward renewable energy companies. Big investors like BlackRock Inc., the world's largest asset manager, overseeing $7.8 trillion, have said they plan to take into account corporations' disclosures of environmental risks, including carbon footprints.
According to Wells Fargo senior market strategist Scott Wren, "Since the start of the year, cyclicals have outperformed, with energy gaining the most, up 15%, helped by higher oil prices. Financials were up 5.1%, and materials were up 4.4%."
"All of these cyclicals stocks have moved in advance of what we think will be a higher rate move. Rates have moved up to support that idea," Wilson said. "We think they could go up quite a bit more over the course of the next several months."
As well, The iShares Global Clean Energy ETF, which tracks S&P Global's index of clean energy companies around the world, has risen by nearly 30% since July 2020. The fund's assets under management swelled to $1.2 billion from $431 million at the start of the year.
GSFI CEO Eric Fain is encouraged by the increased opportunity Biden's new agenda could mean for companies like Green Stream Holdings. "I believe we are at the dawn of a new era for renewable energy and, in turn, an increased access to market with ability to expedite shareholder value as we cultivate new opportunities alongside our current projects in New York, including:
160 Imlay street. Brooklyn Ny
8012 Tonelle Ave; North Bergen, NJ
44 Victory Blvd; Staten Island, NY
111 Station Road; Bellport, NY
15-17 Sherwood Ave - Yonkers Proposal
4290 Austin Blvd; Island Park, NY
"We have recently moved our headquarters to a functional work/living space which belongs to our flagship project at 160 Imlay Street in Brooklyn, New York, where our utility/financing model can be seen in action as we continue to develop opportunities in the NE United States and beyond."
Project To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_003full.jpg
"This is all in line with NY Governor Cuomo's recent announcement of a clean energy initiative which unveiled the details of the awards for 21 large-scale solar, wind, and energy storage projects across upstate New York, totaling 1,278 megawatts of new renewable capacity," states Fain.
Shareholders-visit greenrainsolar.com. where you can view Green Stream's news, filings and even a live Level 2 stream, along with other company information.
Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004.jpg GSFI - Strategic Moves To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004full.jpg
https://www.nasdaq.com/press-release/green-stream-holdings-anticipates-sunny-forecast-for-renewable-energy-market-rally-as
$GSFI Green Stream Holdings Anticipates Sunny Forecast for Renewable Energy - Market Rally as U.S. Stocks Soar Just Hours Before Biden Inauguration
JAN 20, 2021 11:59AM EST
Malibu, California--(Newsfile Corp. - January 20, 2021) - Green Stream Holdings Inc. (OTC PINK: GSFI) ("the Company") ("Green Stream") (http://www.GreenRainSolar.com ), an emerging leader in the solar utility and finance space, announces today what it believes to be a new era for Renewable Energy and its Solar Utilities/Financing model as stocks rise in advance of the inauguration of Joe Biden as the 46th President of the United States.
To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_002full.jpg
Biden's agenda is to transition the U.S. from an economy reliant on fossil fuels to one driven by wind, solar and other renewable-energy sources. The shift from fossil-fuel companies to renewable-energy firms accelerated during the Trump administration, despite the president's vows to support the U.S. coal and petroleum industries.
Big and small investors have moved their assets away from fossil-fuel producers and toward renewable energy companies. Big investors like BlackRock Inc., the world's largest asset manager, overseeing $7.8 trillion, have said they plan to take into account corporations' disclosures of environmental risks, including carbon footprints.
According to Wells Fargo senior market strategist Scott Wren, "Since the start of the year, cyclicals have outperformed, with energy gaining the most, up 15%, helped by higher oil prices. Financials were up 5.1%, and materials were up 4.4%."
"All of these cyclicals stocks have moved in advance of what we think will be a higher rate move. Rates have moved up to support that idea," Wilson said. "We think they could go up quite a bit more over the course of the next several months."
As well, The iShares Global Clean Energy ETF, which tracks S&P Global's index of clean energy companies around the world, has risen by nearly 30% since July 2020. The fund's assets under management swelled to $1.2 billion from $431 million at the start of the year.
GSFI CEO Eric Fain is encouraged by the increased opportunity Biden's new agenda could mean for companies like Green Stream Holdings. "I believe we are at the dawn of a new era for renewable energy and, in turn, an increased access to market with ability to expedite shareholder value as we cultivate new opportunities alongside our current projects in New York, including:
160 Imlay street. Brooklyn Ny
8012 Tonelle Ave; North Bergen, NJ
44 Victory Blvd; Staten Island, NY
111 Station Road; Bellport, NY
15-17 Sherwood Ave - Yonkers Proposal
4290 Austin Blvd; Island Park, NY
"We have recently moved our headquarters to a functional work/living space which belongs to our flagship project at 160 Imlay Street in Brooklyn, New York, where our utility/financing model can be seen in action as we continue to develop opportunities in the NE United States and beyond."
Project To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_003full.jpg
"This is all in line with NY Governor Cuomo's recent announcement of a clean energy initiative which unveiled the details of the awards for 21 large-scale solar, wind, and energy storage projects across upstate New York, totaling 1,278 megawatts of new renewable capacity," states Fain.
Shareholders-visit greenrainsolar.com. where you can view Green Stream's news, filings and even a live Level 2 stream, along with other company information.
Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004.jpg GSFI - Strategic Moves To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6720/72426_c77e571b24d93902_004full.jpg
https://www.nasdaq.com/press-release/green-stream-holdings-anticipates-sunny-forecast-for-renewable-energy-market-rally-as
$MCET great interest here! It grows and grows!
$MCET great interest here! It grows and grows!
Market Makers on radar! LONG confirmed! More and More VOLUME! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Market Makers on radar! LONG confirmed! More and More VOLUME! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
$MCET Granted Patent Drug: Multicell Technologies Immortalized Hepatocytes Doc Type Granted Patent in US, Europe and Germany!
Immortalized Human Hepatocyte Cell Lines
[0084]In another preferred embodiment of the present invention, the cell lines proliferate easily in media. Preferably, the cell lines proliferate easily in a serum-free media. More preferably, the cell lines proliferate easily in MFE media (MultiCell Technologies Inc., Providence, R.I., USA; XenoTech, LLC, Lenexa, Kans., USA).
https://www.lens.org/lens/patent/167-627-709-236-287/fulltext
INTRODUCTION
Primary cultures of human hepatocytes are widely used to evaluate the cytochrome P450 (CYP) enzyme-inducing potential and/or toxicity of drug candidates. However, the availability of human hepatocytes for this purpose is limited and erratic, and there are large inter-individual differences in the magnitude of induction (due to differences in both
"control" and "induced" CYP activities). Immortalized human hepatocytes, Fa2N-4, developed by Multicell Technologies, (Warwick, RI) have the potential to overcome these limitations. The cells, immortalized through transformation of human hepatocytes with SV40 T antigen, display in vitro cell morphology that closely resembles primary human hepatocytes (Figure 1). The Fa2N-4 cells retain many of the characteristics of primary hepatocytes, including the inducibility of multiple CYP mRNAs and enzyme activities (Mills et al., 2002; Morris et al., 2003; Czerwinski et al., 2003). In this study, we further characterized the ability of these cells to respond to enzymeinducing xenobiotics. Additionally, we examined the toxicity profile of multiple enzyme inducers in primary hepatocytes and Fa2N-4 cells.
MATERIALS AND METHODS
The Fa2N-4 cells were propagated in MFE media (Multicell Technologies) on plasticware coated with Vitrogen (Cohesion Technologies, Palo Alto, CA) and maintained at 37°C, 5% CO2, 95% humidity. Immortalized hepatocytes were grown to confluency in 24 or 96-well plates and treated with enzyme inducers for up to 6 consecutive days with daily changes of medium. All enzyme inducers were dissolved in DMSO (final concentration of solvent 0.1%, v/v). Primary human hepatocytes were isolated and cultured as described (LeCluyse et al., 2000, Madan et al., 2003). Enzymatic activities were determined by incubating the cells with CYPspecific substrates. Metabolite formation was measured by LC-MS as summarized in Table 1.
The Use of Immortalized Hepatocytes in Induction Studies https://www.xenotech.com/access-adme-research-resources/resources/the-use-of-immortalized-hepatocytes-in-induction-studies/
https://www.xenotech.com/wp-content/uploads/2004/08/The-Use-of-Immortalized-Hepatocytes-in-Induction-Studies.pdf
Multicell Technologies Immortalized Hepatocytes Doc Type Granted Patent in US, Europe and Germany!
Multicell Technologies Immortalized Hepatocytes
InventorJin LiuRonald A. FarisCurrent Assignee Multicell Technologies Inc
US 7566567 B2
Doc Type: Granted Patent
ID: lens.org/167-627-709-236-287
Jul 28, 2009
Application US10/574,163 events
2003-10-10
Priority to US51050903P
2004-10-07
Application filed by Multicell Technologies Inc
2007-01-04
Publication of US20070004039A1
2009-07-28
Publication of US7566567B2
2009-07-28
Application granted
Status Active
2025-01-13
Adjusted expiration
https://patents.google.com/patent/US7566567B2/un
EP 1704227 B1
Doc Type: Granted Patent
ID: lens.org/097-040-197-694-101
Jan 27, 2010
EP1704227B1 European Patent Office
Application EP04794437A events
2003-10-10
Priority to US51050903P
2004-10-07
Application filed by Multicell Technologies Inc
2004-10-07
Priority to PCT/US2004/033091
2006-09-27
Publication of EP1704227A1
2007-01-17
Publication of EP1704227A4
2010-01-27
Application granted
2010-01-27
Publication of EP1704227B1
Status Active
2024-10-07
Anticipated expiration
https://patents.google.com/patent/EP1704227B1/en
DE 602004025380 D1
Doc Type: Granted Patent
ID: lens.org/082-791-344-403-259
Mar 18, 2010
Application DE602004025380T events
2003-10-10
Priority to US51050903P
2004-10-07
Application filed by Multicell Technologies Inc
2004-10-07
Priority to PCT/US2004/033091
2010-03-18
Publication of DE602004025380D1
Status Active
2024-10-08
Anticipated expiration
https://patents.google.com/patent/DE602004025380/D1
Family timeline https://www.lens.org/lens/patent/167-627-709-236-287/family
Immortalized Hepatocytes https://www.lens.org/lens/patent/167-627-709-236-287
$MCET Granted Patent Drug: Multicell Technologies Immortalized Hepatocytes Doc Type Granted Patent in US, Europe and Germany!
Immortalized Human Hepatocyte Cell Lines
[0084]In another preferred embodiment of the present invention, the cell lines proliferate easily in media. Preferably, the cell lines proliferate easily in a serum-free media. More preferably, the cell lines proliferate easily in MFE media (MultiCell Technologies Inc., Providence, R.I., USA; XenoTech, LLC, Lenexa, Kans., USA).
https://www.lens.org/lens/patent/167-627-709-236-287/fulltext
INTRODUCTION
Primary cultures of human hepatocytes are widely used to evaluate the cytochrome P450 (CYP) enzyme-inducing potential and/or toxicity of drug candidates. However, the availability of human hepatocytes for this purpose is limited and erratic, and there are large inter-individual differences in the magnitude of induction (due to differences in both
"control" and "induced" CYP activities). Immortalized human hepatocytes, Fa2N-4, developed by Multicell Technologies, (Warwick, RI) have the potential to overcome these limitations. The cells, immortalized through transformation of human hepatocytes with SV40 T antigen, display in vitro cell morphology that closely resembles primary human hepatocytes (Figure 1). The Fa2N-4 cells retain many of the characteristics of primary hepatocytes, including the inducibility of multiple CYP mRNAs and enzyme activities (Mills et al., 2002; Morris et al., 2003; Czerwinski et al., 2003). In this study, we further characterized the ability of these cells to respond to enzymeinducing xenobiotics. Additionally, we examined the toxicity profile of multiple enzyme inducers in primary hepatocytes and Fa2N-4 cells.
MATERIALS AND METHODS
The Fa2N-4 cells were propagated in MFE media (Multicell Technologies) on plasticware coated with Vitrogen (Cohesion Technologies, Palo Alto, CA) and maintained at 37°C, 5% CO2, 95% humidity. Immortalized hepatocytes were grown to confluency in 24 or 96-well plates and treated with enzyme inducers for up to 6 consecutive days with daily changes of medium. All enzyme inducers were dissolved in DMSO (final concentration of solvent 0.1%, v/v). Primary human hepatocytes were isolated and cultured as described (LeCluyse et al., 2000, Madan et al., 2003). Enzymatic activities were determined by incubating the cells with CYPspecific substrates. Metabolite formation was measured by LC-MS as summarized in Table 1.
The Use of Immortalized Hepatocytes in Induction Studies https://www.xenotech.com/access-adme-research-resources/resources/the-use-of-immortalized-hepatocytes-in-induction-studies/
https://www.xenotech.com/wp-content/uploads/2004/08/The-Use-of-Immortalized-Hepatocytes-in-Induction-Studies.pdf
Multicell Technologies Immortalized Hepatocytes Doc Type Granted Patent in US, Europe and Germany!
Multicell Technologies Immortalized Hepatocytes
InventorJin LiuRonald A. FarisCurrent Assignee Multicell Technologies Inc
US 7566567 B2
Doc Type: Granted Patent
ID: lens.org/167-627-709-236-287
Jul 28, 2009
Application US10/574,163 events
2003-10-10
Priority to US51050903P
2004-10-07
Application filed by Multicell Technologies Inc
2007-01-04
Publication of US20070004039A1
2009-07-28
Publication of US7566567B2
2009-07-28
Application granted
Status Active
2025-01-13
Adjusted expiration
https://patents.google.com/patent/US7566567B2/un
EP 1704227 B1
Doc Type: Granted Patent
ID: lens.org/097-040-197-694-101
Jan 27, 2010
EP1704227B1 European Patent Office
Application EP04794437A events
2003-10-10
Priority to US51050903P
2004-10-07
Application filed by Multicell Technologies Inc
2004-10-07
Priority to PCT/US2004/033091
2006-09-27
Publication of EP1704227A1
2007-01-17
Publication of EP1704227A4
2010-01-27
Application granted
2010-01-27
Publication of EP1704227B1
Status Active
2024-10-07
Anticipated expiration
https://patents.google.com/patent/EP1704227B1/en
DE 602004025380 D1
Doc Type: Granted Patent
ID: lens.org/082-791-344-403-259
Mar 18, 2010
Application DE602004025380T events
2003-10-10
Priority to US51050903P
2004-10-07
Application filed by Multicell Technologies Inc
2004-10-07
Priority to PCT/US2004/033091
2010-03-18
Publication of DE602004025380D1
Status Active
2024-10-08
Anticipated expiration
https://patents.google.com/patent/DE602004025380/D1
Family timeline https://www.lens.org/lens/patent/167-627-709-236-287/family
Immortalized Hepatocytes https://www.lens.org/lens/patent/167-627-709-236-287
Market Makers decide! It's going up! Purchase offers confirmed! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/
Market Makers decide! It's going up! Purchase offers confirmed! https://investorshub.advfn.com/MultiCell-Technologies-MCET-2694/